1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America injectors Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America injectors Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America injectors Market Regional Analysis
6.2 North America injectors Market Revenue 2017-2027 (US$ Million)
6.3 North America injectors Market Forecast Analysis
7. North America injectors Market Analysis – by Type
7.1 On-body Injectors and Off-body Injectors
- 7.1.1 Overview
- 7.1.2 On-body Injectors and Off-body Injectors: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America injectors Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Diabetes
- 8.2.1 Overview
- 8.2.2 Diabetes: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Autoimmune Disease
- 8.3.1 Overview
- 8.3.2 Autoimmune Disease: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Cardiovascular Disease
- 8.4.1 Overview
- 8.4.2 Cardiovascular Disease: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Other Applications
- 8.5.1 Overview
- 8.5.2 Other Applications: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America injectors Market Analysis – by End User
9.1 Homecare Setting
- 9.1.1 Overview
- 9.1.2 Homecare Setting: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Other End Users
- 9.3.1 Overview
- 9.3.2 Other End Users: North America injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America injectors Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America injectors Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America injectors Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America injectors Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America injectors Market Breakdown, by Type
- 10.2.1.1.2 US: North America injectors Market Breakdown, by Application
- 10.2.1.1.3 US: North America injectors Market Breakdown, by End User
- 10.2.1.2 Canada:
North America injectors Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America injectors Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America injectors Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America injectors Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America injectors Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America injectors Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America injectors Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America injectors Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 B. Braun Melsungen ag
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Smith & Nephew
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Mölnlycke Health Care AB
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Convatec Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BD
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cardinal Health Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Schülke and Mayr
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Coloplast Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Reckitt Benckiser Group plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Serag-Wiessner Gmbh and CO.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations